DUTCH blog

YES! Urine testing can be used to monitor transdermal estrogen creams or gels

By Mark Newman, MS

In this blog, you will see the data that has led us to the following conclusions about monitoring transdermal estrogen: Serum and urine (DUTCH) testing…

Read More

Monitoring patients on transdermal testosterone replacement

By Mark Newman, MS

In our previous blog, “Yes! Urine Testing Can Be Used to Monitor Transdermal Estrogen Creams or Gels”, we concluded that transdermal estradiol is effectively monitored…

Read More

Why Assessing Progesterone Is Better with DUTCH

By Mark Newman, MS

In July of 2017, we had an excellent post from Dr. Schroeder about why we test cycling women within days 19-22 of their cycle. As…

Read More

Is Cortisol causing your patient to struggle with sleep in the middle of the night?

By Carrie Jones, ND, MPH

The DUTCH Plus now has the answer! When patients suffer from insomnia, the 5 salivary cortisol measurements on the DUTCH Plus may not be enough…

Read More

Estrogen and the Aging Brain

By Clinical Consulting Team

A growing body of research suggests estrogen levels throughout a woman’s life may influence her risk of developing Alzheimer’s disease. In this case, more estrogen…

Read More

Metabolized Versus Free Cortisol: Understanding the Difference

By Carrie Jones, ND, MPH

The DUTCH Test™ is well-recognized for its reporting that is not available from other laboratories. The cortisol metabolites in the adrenal section are among the…

Read More

What Does “Waking (A)” Represent in the Daily Free Cortisol Pattern?

By Carrie Jones, ND, MPH

Is your patient interested in knowing what their cortisol levels are in the middle of the night? Do they suffer from insomnia or wake routinely…

Read More

Why we test during days 19-22 of a 28-day cycle

By Elise Schroeder, ND

A common question both practitioners and patients have is, when should I test my hormones? This depends, of course, on whether someone is having regular…

Read More

Using the DUTCH Test® for Vaginal Atrophy

By Elise Schroeder, ND

Vaginal atrophy is one of the top complaints among menopausal women and women experiencing estrogen deprivation therapy post breast cancer. Symptoms commonly include: dryness, general…

Read More

The Potential Benefits of “4-Spot Urine Testing” for HPA Axis Assessment

By Mark Newman, MS

Written by Carrie Jones, ND and Mark Newman, MS The health of the entire hypothalamic-pituitary-adrenal (HPA) axis is critically important for maintaining proper health primarily…

Read More